‘No Identifiable Reason’ for 50% of Antipsychotic Use in ADHD

 ADHD in the News 2019-11-07

Only about 50% of antipsychotic prescriptions for children and youth who have been newly diagnosed with attention-deficit/hyperactivity disorder (ADHD) have an identifiable clinical indication. Furthermore, fewer than half of these patients receive initial treatment with stimulants ― the recommended first-line pharmacologic therapy ― results of a national analysis show.